Data from Folia Cardiologica - Curated by EPG Health - Date available 01 January 2017


Free full text

Original date published

1 January 2017

Original format

Print publication

A 62-year-old man was admitted due to exacerbation of chronic heart failure symptoms to IV New York Heart Association class. Despite the standard pharmacotherapy of acute heart failure, the patient developed symptoms of organ hypoperfusion, followed by oliguria and anuria. The patient was qualified for levosimendan treatment, resulting in stabilization of his clinical status in subsequent days. The study presents the current knowledge of levosimendan use in acute heart failure.

Data sources

Access full article


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more

Related Content